Oxford BioMedica H1 revenue rises as manufacturing increases
Oxford BioMedica says its H1 revenue rose on increased manufacturing, per a company press release summarized by Reuters/TradingView News.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.